DreaMed Diabetes, is a developer of AI-based algorithms and data analytics focused on delivering expert-level care to all patients with diabetes. DreaMed's endo.digital platform is an FDA-cleared AI-based clinical decision support system which allows healthcare systems the ability to frequently monitor and optimize insulin dosing for patients across all care settings and improve patient outcomes. Endo.digital is currently being deployed at leading healthcare systems in the U.S.